These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25484104)

  • 1. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
    Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
    Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of the principal characteristics of gastroesophageal reflux during the recumbent period using integrated actigraphy-acquired information.
    Poh CH; Gasiorowska A; Allen L; Navarro-Rodriguez T; Mizyed I; Powers J; Moty B; Quan SF; Willis MR; Ashpole N; Malagon I; Fass R
    Am J Gastroenterol; 2010 May; 105(5):1024-31. PubMed ID: 19904242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conscious awakenings are commonly associated with Acid reflux events in patients with gastroesophageal reflux disease.
    Poh CH; Allen L; Gasiorowska A; Navarro-Rodriguez T; Quan SF; Malagon I; Powers J; Willis MR; Ashpole N; Fass R
    Clin Gastroenterol Hepatol; 2010 Oct; 8(10):851-7. PubMed ID: 20621628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naps are associated more commonly with gastroesophageal reflux, compared with nocturnal sleep.
    Nasrollah L; Maradey-Romero C; Jha LK; Gadam R; Quan SF; Fass R
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):94-9. PubMed ID: 24907504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study.
    Jha LK; Fass R; Gadam R; Maradey-Romero C; Nasrollah L; Hershcovici T; Quan SF; Dickman R
    J Clin Gastroenterol; 2016 Feb; 50(2):e19-24. PubMed ID: 25887111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo.
    Johnson DA; Le Moigne A; Li J; Pollack C; Nagy P
    Clin Drug Investig; 2016 Jul; 36(7):531-8. PubMed ID: 27074935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
    Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
    Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn.
    Martinucci I; de Bortoli N; Savarino E; Piaggi P; Bellini M; Antonelli A; Savarino V; Frazzoni M; Marchi S
    Neurogastroenterol Motil; 2014 Apr; 26(4):546-55. PubMed ID: 24433456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
    Johnson D; Crawley JA; Hwang C; Brown K
    Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
    Johnson DA; Orr WC; Crawley JA; Traxler B; McCullough J; Brown KA; Roth T
    Am J Gastroenterol; 2005 Sep; 100(9):1914-22. PubMed ID: 16128933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
    Kindt S; Imschoot J; Tack J
    Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of recumbent reflux by multichannel intraluminal impedance pH testing for patients with gastroesophageal reflux disease and sleep disturbance.
    Hoshino M; Omura N; Yano F; Tsuboi K; Yamamoto SR; Akimoto S; Masuda T; Kashiwagi H; Yanaga K
    Esophagus; 2020 Jul; 17(3):348-354. PubMed ID: 31970574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
    Orlando RC; Monyak JT; Silberg DG
    Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study.
    Moawad FJ; Betteridge JD; Boger JA; Cheng FK; Belle LS; Chen YJ; Maydonovitch CL; Wong RK
    Aliment Pharmacol Ther; 2013 May; 37(10):1011-8. PubMed ID: 23560727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of nighttime reflux assessed using multichannel intraluminal impedance pH monitoring and a portable electroencephalograph.
    Fujiwara Y; Kohata Y; Nakahara K; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Watanabe T; Arakawa T
    Dis Esophagus; 2016 Apr; 29(3):278-84. PubMed ID: 25604848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
    Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.